The new sec rules for spacs is no extension after 3 years, Tilgly acquisition has until April 16th or plus ten days to complete a business combination, their new sec filings are asking for shareholders vote for extension with no set meeting date, transfer agent with Continental trust which deal only with government securities (Lcyb/Bioamber is possible) https://cooleypubco.com/2024/09/25/nyse-withdraws-proposal-spacs/
Also Verde Bioresins going public with NXU after ten days of a 1 to 20 reverse split and name change VRDE, (by April 10th) (the price could go to $60 after name change (biodegradable plastics and 600B market who were originally going public with Tilgly aquisition and Vinmar) does Verde have anything to do with Bioamber's technology or Lcy biotechnology? Could they be holding our shares to issue new shares for Bioamber at $60/share??